Drug Repurposing Analysis for Colorectal Cancer through Network Medicine Framework: Novel Candidate Drugs and Small Molecules
dc.authorid | UNAL, ULKU/0000-0001-8063-5599 | |
dc.authorid | GOV, ESRA/0000-0002-5256-4778 | |
dc.contributor.author | Unal, Ulku | |
dc.contributor.author | Gov, Esra | |
dc.date.accessioned | 2025-01-06T17:37:02Z | |
dc.date.available | 2025-01-06T17:37:02Z | |
dc.date.issued | 2023 | |
dc.description.abstract | This study aimed to reveal the drug-repurposing candidates for colorectal cancer (CRC) via drug-repurposing methods and network biology approaches. A novel, differentially co-expressed, highly interconnected, and co-regulated prognostic gene module was identified for CRC. Based on the gene module, polyethylene glycol (PEG), gallic acid, pyrazole, cordycepin, phenothiazine, pantoprazole, cysteamine, indisulam, valinomycin, trametinib, BRD-K81473043, AZD8055, dovitinib, BRD-A17065207, and tyrphostin AG1478 presented as drugs and small molecule candidates previously studied in the CRC. Lornoxicam, suxamethonium, oprelvekin, sirukumab, levetiracetam, sulpiride, NVP-TAE684, AS605240, 480743.cdx, HDAC6 inhibitor ISOX, BRD-K03829970, and L-6307 are proposed as novel drugs and small molecule candidates for CRC. | |
dc.description.sponsorship | Health Institutes of Turkey (TUSEB); [2019-TA-01/3436] | |
dc.description.sponsorship | U. U. was supported in the context of the Council of Higher Education (YOK) 100/2000 Doctoral Fellowship Program of Turkey. This study was supported by the Health Institutes of Turkey (TUSEB) in the context of the project 2019-TA-01/3436. | |
dc.identifier.doi | 10.1080/07357907.2023.2255672 | |
dc.identifier.endpage | 733 | |
dc.identifier.issn | 0735-7907 | |
dc.identifier.issn | 1532-4192 | |
dc.identifier.issue | 8 | |
dc.identifier.pmid | 37682113 | |
dc.identifier.scopus | 2-s2.0-85171652106 | |
dc.identifier.scopusquality | Q3 | |
dc.identifier.startpage | 713 | |
dc.identifier.uri | https://doi.org/10.1080/07357907.2023.2255672 | |
dc.identifier.uri | https://hdl.handle.net/20.500.14669/2087 | |
dc.identifier.volume | 41 | |
dc.identifier.wos | WOS:001069407000001 | |
dc.identifier.wosquality | Q3 | |
dc.indekslendigikaynak | Web of Science | |
dc.indekslendigikaynak | Scopus | |
dc.indekslendigikaynak | PubMed | |
dc.language.iso | en | |
dc.publisher | Taylor & Francis Inc | |
dc.relation.ispartof | Cancer Investigation | |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | |
dc.rights | info:eu-repo/semantics/openAccess | |
dc.snmz | KA_20241211 | |
dc.subject | Colorectal cancer | |
dc.subject | computational systems biology | |
dc.subject | bioinformatics | |
dc.subject | drug repurposing | |
dc.subject | candidate drugs | |
dc.title | Drug Repurposing Analysis for Colorectal Cancer through Network Medicine Framework: Novel Candidate Drugs and Small Molecules | |
dc.type | Article |